drugset / Trial / NCT05838170
Study of TP-04 in Participants With Papulopustular Rosacea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being done to evaluate the safety, tolerability, and efficacy of the study drug, TP-04, in participants with papulopustular rosacea (PPR).
Timeline
- Start
- 2023-03-01
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lotilaner | Small molecule | 2 % | — |